Discover

KVUE
Kenvue Inc.
17.20
19400 x 17.18
22600 x 17.20
bid
ask
-
0.02
0.12%
21000 @ 07:54 PM
17.18 -0.02 (0.12%)
Ytd-0.29%
1y9.35%
17.16
day range
17.38
14.11
52 week range
19.83
Open17.33Prev Close17.22Low17.16High17.38Mkt Cap33.04B
Vol14.00MAvg Vol22.21MEPS0.85P/E20.24Forward P/E13.89
Beta0.43Short Ratio2.12Inst. Own95.91%Dividend0.84Div Yield4.88
Ex Div Date09-21Earning11-0550-d Avg18.67200-d Avg18.031yr Est19.50
Earning
DateForEstimateReportedSurprisesurprise %
2026-11-022026-090.28N/AN/AN/A
2026-08-062026-060.320.31-0.01-2.73%
2026-05-072026-030.260.320.0622.09%
2026-02-172025-120.220.270.0521.24%
2025-11-032025-090.260.280.027.61%
2025-08-072025-060.280.290.012.95%
Upgrade / Downgrade
DateFirmActionFromTo
2026-08-11UBSUpgradeNeutralNeutral
2026-07-21BarclaysUpgradeEqual-WeightEqual-Weight
2026-07-16UBSUpgradeNeutralNeutral
2026-04-15CitigroupUpgradeNeutralNeutral
2026-04-14BarclaysUpgradeEqual-WeightEqual-Weight
2026-04-07UBSUpgradeNeutralNeutral
Profile
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
Insider Holder
DateNameRelationQuantityDescription
2026-03-09ALVARADO LUANIChief Operating Officer61.42KConversion of Exercise of derivative security
2026-03-09LAWSON CARLTONOfficer111.42KConversion of Exercise of derivative security
2025-03-04MEURER JANOfficer33.18KConversion of Exercise of derivative security
2025-03-04MONGON THIBAUTChief Executive Officer216.47KConversion of Exercise of derivative security
2025-12-14PERRY KIRK LChief Executive Officer62.55KConversion of Exercise of derivative security
2025-03-04RUH PAULChief Financial Officer56.20KConversion of Exercise of derivative security
Institution Ownership
Report DateOrganizationPositionValuePercentage
2026-06-29FMR, LLC157.05M2.71B8.18%
2026-06-29Blackrock Inc.150.83M2.60B7.85%
2026-06-29Vanguard Capital Management LLC125.31M2.16B6.52%
2026-06-29State Street Corporation121.62M2.09B6.33%
2026-06-29Vanguard Portfolio Management LLC93.30M1.61B4.86%
2026-06-29Geode Capital Management, LLC52.02M896.07M2.71%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2026-06-29VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund60.96M1.05B3.17%
2026-06-29VANGUARD INDEX FUNDS-Vanguard 500 Index Fund49.76M857.05M2.59%
2026-06-29VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund41.60M716.63M2.17%
2026-08-30iShares Trust-iShares Core S&P 500 ETF25.57M440.40M1.33%
2026-07-30Fidelity Concord Street Trust-Fidelity 500 Index Fund24.83M427.66M1.29%
2026-08-30SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust23.52M405.09M1.22%
Dividend
DividendDate
0.212026-09-21
0.212026-08-12
0.20752026-05-13
0.20752026-02-11
0.20752025-11-12
0.20752025-08-13